TimesSquare Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-822,012
| Closed | -$25.9M | – | 199 |
|
|
2022
Q1 | $25.9M | Sell |
822,012
-142,770
| -15% | -$4.51M | 0.29% | 135 |
|
|
2021
Q4 | $39M | Buy |
964,782
+312,542
| +48% | +$12.6M | 0.35% | 123 |
|
|
2021
Q3 | $22.7M | Sell |
652,240
-35,300
| -5% | -$1.23M | 0.2% | 163 |
|
|
2021
Q2 | $18.9M | Sell |
687,540
-32,000
| -4% | -$879K | 0.15% | 182 |
|
|
2021
Q1 | $20.2M | Sell |
719,540
-107,730
| -13% | -$3.03M | 0.17% | 175 |
|
|
2020
Q4 | $21.5M | Sell |
827,270
-23,500
| -3% | -$610K | 0.17% | 173 |
|
|
2020
Q3 | $14.6M | Sell |
850,770
-34,100
| -4% | -$584K | 0.14% | 190 |
|
|
2020
Q2 | $21.9M | Buy |
+884,870
| New | +$21.9M | 0.21% | 172 |
|